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showed the decrease in viral titer as compared to the mock
infected mouse.
Conclusion: Thus, this strategy represents a versatile
system as a single carrier protein could be easily and
rapidly coupled to the desired peptide to sensitize the
APCs and thus activate the host immune system against the
pathogenic virus.
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Objective: To explore the pandemic characteristics and
effective treatment measures of H1N1 inﬂuenza.
Methods: A total of 27 patients diagnosed as H1N1 inﬂuenza
from Nanfang hospital (from November 2009 to February
2010) were analyzed.
Results: The study included 15 Males and 12 females aged
from 5 to 63 years (average:29.1). From 27 patients,
16 (59.3%) had different parimary disease. The most
common symptoms were fever (96.3%), cough (81.5%),
dyspnea (59.3%), pneumonia or bronchitis (55.6%)
and pharynx pain (44.4%). Other complications, such
as renal impairment (13.3%), severe gastrointestinal
symptoms (6.7%) and change of consciousness (7.4%), were
found in some patients. Fever period of 12 severe patients
with primary disease was 5 17 (10.6±384) days. A series
of measures like antiviral, antibacterial, management of
the respiratory tract and Glucocorticoids Ictus therapies
were taken according to patients’ conditions. For the 27
patients studied, 22 (81.5%) were cured, and 5 (18.5%)
died. Of 5 cases dead, 4 had serious primary diseases and
only 1 died from H1N1. No case of nosocomial infection was
found in the study.
Conclusion: The complication of pneumonia was more
frequently appeared in severe patients with inﬂuenza H1N1.
Most patients could be cured by positive and effective
measures. However, the mortality rate of serious patients
with primary diseases was still high.
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Objective: To explore the epidemiological and clinical
characteristics of patients with hand, foot and mouth
disease (HFMD) in eastern Zhejiang province from March
2007 to August 2009.
Methods: The distribution of gender, age, time of onset,
region and clinical data were analyzed by descriptive
epidemiological methods.
Results: A high incidence of HFMD occurred mostly in
infants aged below 4 years (95.9%), especially aged 1 to
3 years (82.6%). Males were more likely to acquire the
disease than females, and the ratio was 1.7:1. Onset of
HFMD was most in April to July, but the peak incidence in
2009 (April) was earlier than in 2008 (May and June). People
living in the district and county-level city of population
density and foreign population were more likely to acquire
the disease. Typical clinical presentations included fever
and characteristic rashes, and the incidence rate of rashes
was up to 97.77%. Characteristics of the rashes were
painless rashes which located in hand, foot, buttock and/or
knees and painful oral ulcers. The ratio of patients with
hyperpyrexia was 34.86%, with leukocytosis was 48.11% (but
severe cases was rare), with elevated creatine kinase (CK)
was 20.94% and elevated CK-MB was 76.28%, but abnormal
electrocardiographic (ECG) pattern was rare, with elevated
FBG was 13.36%. There were no correspondence among the
abnormal high levels of CK, CK-MB, ALT, AST and abnormal
ECG.
Conclusions: HFMD will be fully recovered in approximately
one week by conventional anti-virus treatment and
symptomatic treatment. But it also needs our intensive
care to prevent and treat various complications. Traditional
Chinese medicine has comparative advantage and should be
promoted. Except positive isolation, disease treatment and
epidemic site treatment, effective health education is also
important to disease prevention.
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Background: Hepatic Schistosomal ﬁbrosis is a continuous
process. Bacteria may reach the liver via the portal venous
blood from the intestinal tract & abnormalities in the liver
circulation could abolish the ﬁlter effect of the liver.
Aim: To determine whether bacteria are present or not, to
know its species and evaluate its role in the pathogenesis
of Schistosomal liver ﬁbrosis.
Subjects and Methods:
Group A
1. 25 patients with Schistosomal hepatic ﬁbrosis were
submitted to clinical examination & the consent was
written by each patient before splenectomy.
2. Portal pressure was measured.
3. Excisional liver biopsy was taken for histopathology
and culture.
4. 15 ml of portal blood was aspirated by veinpuncture
from the portal vein and 15 ml venous blood was
simultaneously taken from the anticubital vein.
5. Each 5 ml of the portal and venous blood were added
to 10ml of 0.05% sulphonated broth.
6. The blood broth tubes were incubated aerobicaly,
anaerobically and in 5% CO2.
Group B. Portal and systemic blood samples were taken from
6 non-bilharzial patients as control group during peptic
ulcer operations.
Results:
1. The systemic blood of all patients & the liver biopsy
cultures proved to be sterile.
2. Three portal blood samples were excluded due to
contamination.
3. 22.7% of portal blood samples from Schistosomal patients
were positive for bacteria (Staphyloccus aureus from 3
patients, Escherichia coli from one patient & Bacteroides
fragilis from one patient.
4. Samples of portal and systemic blood from controls were
sterile.
Conclusions:
1. Portal bacteraemia in Schistosomal hepatic ﬁbrosis
explains the occurrence of parenchymal involvement in
such patients by the effect of the viable bacteria or its
toxin on the hepatocytes.
